Literature DB >> 30382492

Gender dysphoria and transgender medicine in the year 2018.

Christian A Koch1,2,3,4, Vin Tangpricha5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30382492     DOI: 10.1007/s11154-018-9471-2

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  17 in total

Review 1.  Gaps in transgender medical education among healthcare providers: A major barrier to care for transgender persons.

Authors:  Sira Korpaisarn; Joshua D Safer
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

2.  Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis.

Authors:  E J Giltay; L J Gooren; J J Emeis; T Kooistra; C D Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

3.  Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

Authors:  Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

Review 4.  Endocrine treatment of aging transgender people.

Authors:  Louis J Gooren; Guy T'Sjoen
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

5.  Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.

Authors:  Darios Getahun; Rebecca Nash; W Dana Flanders; Tisha C Baird; Tracy A Becerra-Culqui; Lee Cromwell; Enid Hunkeler; Timothy L Lash; Andrea Millman; Virginia P Quinn; Brandi Robinson; Douglas Roblin; Michael J Silverberg; Joshua Safer; Jennifer Slovis; Vin Tangpricha; Michael Goodman
Journal:  Ann Intern Med       Date:  2018-07-10       Impact factor: 25.391

Review 6.  Transgender medicine - puberty suppression.

Authors:  Leonidas Panagiotakopoulos
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

Review 7.  Cardiovascular health in transgender people.

Authors:  Michael S Irwig
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

8.  Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.

Authors:  Johannes Ott; Ulrike Kaufmann; Eva-Katrin Bentz; Johannes C Huber; Clemens B Tempfer
Journal:  Fertil Steril       Date:  2009-02-06       Impact factor: 7.329

9.  Emerging topics in transgender medicine.

Authors:  Vin Tangpricha
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

10.  Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS).

Authors:  Florian Schneider; Nina Neuhaus; Joachim Wistuba; Michael Zitzmann; Jochen Heß; Dorothee Mahler; Hermann van Ahlen; Stefan Schlatt; Sabine Kliesch
Journal:  J Sex Med       Date:  2015-11-12       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.